Drug recall · January 15, 2014
Carisoprodol Tablets recall
Why: Presence of Foreign Substance; metal particulates were visually observed in the tablets.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Carisoprodol Tablets, USP, CIV, 350 mg, 500 count bottle, Rx only. Manufactured by Watson Pharma Private Ltd, Verna, Salcette, Goa, 403 722 INDIA. Distributed by: Watson Pharma Ltd, Parsippany, NJ 07054. NDC 0591-5513-05.
- Lots / codes
Lot # 244152A, exp 01/15.
- Quantity
- 4,439 bottles
- Company
- Watson Laboratories Inc, Corona, CA
- Distribution
- Nationwide
- Initiated
- December 23, 2013 · Voluntary: Firm initiated
- Classified
- January 6, 2014
- Reported
- January 15, 2014
- Ended
- August 4, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Carisoprodol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.